May 01, 2025 Semaglutide Shows Potential in Liver Disease Trial Phase 3 trial finds weekly semaglutide 2.4mg significantly improved liver histology in patients with MASH and moderate to advanced fibrosis. Conexiant
May 01, 2025 DDW 2025: 20-Year Screening Program Drives Down Colorectal Cancer Cases, Deaths The ASCO Post
April 30, 2025 AACR 2025: Topical BRAF Inhibitor Under Study for Managing Acneiform Rash The ASCO Post
May 01, 2025 DDW 2025: 20-Year Screening Program Drives Down Colorectal Cancer Cases, Deaths The ASCO Post
April 30, 2025 AACR 2025: Topical BRAF Inhibitor Under Study for Managing Acneiform Rash The ASCO Post
March 24, 2023 100th robotic Ivor Lewis esophagectomy: Important milestone for complex procedure Roswell Park Comprehensive Cancer Center
December 04, 2023 Consuming Navy Beans May Improve Gut Health, Regulate Immune and Inflammatory Processes in Colorectal Cancer Survivors The ASCO Post
April 24, 2025 FDA Approves Nivolumab With Ipilimumab for Unresectable or Metastatic MSI-H/dMMR Colorectal Cancer The ASCO Post